title: Budget Impact Analysis of 13-Valent Pneumococcal Vaccine in Adult Population with Comorbidities or Immunocompromised from the Public Payer Perspective In Brazil.
authors.affiliation: Pfizer, Inc., New York, NY, USA.
authors.forename: C N
authors.initials: CN
authors.lastname: Ferreira
authors.affiliation: Pfizer, Inc., São Paulo, Brazil.
authors.forename: D F
authors.initials: DF
authors.lastname: Manfrin
authors.affiliation: Pfizer, Inc., São Paulo, Brazil.
authors.forename: C S
authors.initials: CS
authors.lastname: Rufino
authors.affiliation: Pfizer, Inc., São Paulo, Brazil.
authors.forename: Y
authors.initials: Y
authors.lastname: Gea
authors.affiliation: ANOVA, Rio de Janeiro, Brazil.
authors.forename: L C
authors.initials: LC
authors.lastname: Haas
authors.affiliation: ANOVA, Rio de Janeiro, Brazil.
authors.forename: R A
authors.initials: RA
authors.lastname: Fernandes